Charlotte Behning

Ms. Charlotte Behning

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2020
Verified
Book Chapter
Closed access
PDF file
ABAlexander Bigerl
Alexander Bigerl
FCFelix Conrads
Felix Conrads
CBCharlotte Behning
Charlotte Behning
MSMohamed Ahmed Sherif
Mohamed Ahmed Sherif
MSMuhammad Saleem
Muhammad Saleem
ANAxel-Cyrille Ngonga Ngomo
Axel-Cyrille Ngonga Ngomo

11 February 2025 in Rheumatology International
Verified
Journal Article
Open access
PDF file
SPSimon Michael Petzinna
Simon Michael Petzinna
JTJan Henrik Terheyden
Jan Henrik Terheyden
LBLara C. Burg
Lara C. Burg
CBClaus-Juergen Bauer
Claus-Juergen Bauer
PKPantelis Karakostas
Pantelis Karakostas
Valentin Sebastian SchäferValentin Sebastian Schäfer
Valentin Sebastian Schäfer
Dear Editor, Giant cell arteritis (GCA) can lead to devastating ophthalmic complications, including sudden complete loss of vision due to anterior ischemic optic neuropathy (AION) secondary to inflammation and occlusion of the short posterior ciliary arteries, which supply the optic nerve head [1, 2]. Ischemia results in retinal changes, such as nerve fiber layer thickening, structural loss and optic disc edema [3, 4]. Assessing ophthalmic involvement in GCA remains challenging. Non-invasive optical coherence tomography angiography (OCTA) of the eye enables us to visualize the retinal and choroidal microcirculation [5, 6]. Additionally, we have recently shown that transorbital ultrasound (TOS) reveals changes in the ocular perfusion of symptomatic eyes in GCA patients [7]. Building on this cohort, we present the first study comparing vascular ultrasound, TOS, and OCTA findings in newly diagnosed GCA patients. The study enrolled newly diagnosed and untreated GCA patients from the Rheumatology Department at the University Hospital Bonn, Germany. Diagnoses were made by a board-certified rheumatologist with patients further meeting the ACR-EULAR classification criteria [8] following ethics approval (ethics committee of the University Hospital Bonn, reference number: 097/18, october 2018). Demographic, clinical, and laboratory data were assessed. Each patient underwent a comprehensive ultrasound examination of superficial temporal, facial, axillary, carotid, and vertebral arteries, along with TOS using a Logiq S8 (2018; GE Healthcare; 6-15 MHz/ 8-18 MHz probes). Flow velocities of the central retinal artery (CRA), including peak systolic velocity (PSV), end diastolic velocity (EDV), resistance index (RI), and optic nerve diameter (OND) were assessed as described previously [7]. OCTA imaging was performed in one eye per participant, prioritizing

13 January 2025 in Ophthalmology Science
Verified
Journal Article
Open access
HDHannah M.P. Dunbar
Hannah M.P. Dunbar
DCDavid P. Crabb
David P. Crabb
CBCharlotte Behning
Charlotte Behning
ABAlison Binns
Alison Binns
AAAmina Abdirahman
Amina Abdirahman
ULUlrich F.O. Luhmann
Ulrich F.O. Luhmann
To examine the extent to which visual function in Beckman age-related macular degeneration (AMD) disease stages differs from age-similar peers with no AMD and, using reference limits derived from those with no AMD, test the hypothesis that people with intermediate AMD (iAMD) have heterogeneous visual function deficits. Cross-sectional analyses of a range of baseline visual function measures from the MACUSTAR study-an international, multicenter (n = 20), noninterventional clinical trial. Five hundred eighty-five participants with iAMD (67% female, mean [standard deviation] age 72 [7] years) were recruited alongside 56 with no AMD (59% female, 68 [6]), 34 with early AMD (79% female, 72 [6]), and 43 with late AMD (49% female, 75 [6]). Participants performed best-corrected visual acuity (BCVA), low luminance visual acuity (LLVA), Moorfields acuity test (MAT), Pelli-Robson contrast sensitivity (PR-CS), small print standardized International reading speed test (SPS), mesopic and scotopic average threshold (MesAT and ScoAT; macular integrity assessment, iCare), and rod intercept time (RIT; AdaptDx, Lumithera). Relationship between each visual function measure and disease classification was examined by linear regression adjusted for age, sex, and phakic status. No AMD data were used to estimate normal reference limits for each visual function test. Intermediate AMD scores were dichotomized against reference limits, and the proportion worse than each limit was calculated. Relative to no AMD, SPS was significantly worse in early AMD (P = 0.001); all measures except SPS were significantly reduced in iAMD (P < 0.02), and all measures were markedly reduced in late AMD (P < 0.0001). Thirty-one point three percent of iAMD participants breached reference limits for PR-CS, 29.4% for RIT, 24.1% for LLVA, 23.2% for MAT, 20.5% for BCVA, 19.8% for MesAT, 17.9% for ScoAT, and 12.6% for SPS. Of the iAMD participants, 69.6% and 42.7% breached ≥1 and ≥2 reference limits, respectively, whereas 33.6% and 5.7% would be expected by chance. A large proportion of people with structurally defined iAMD exhibit heterogeneous visual function deficits outside normal reference limits. This observation may be relevant for the design and inclusion criteria of future interventional trials. Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.

21 August 2024 in Rheumatology International
Verified
Journal Article
Open access
PDF file
Valentin Sebastian SchäferValentin Sebastian Schäfer
Valentin Sebastian Schäfer
LWLone Winter
Lone Winter
DSDirk Skowasch
Dirk Skowasch
CBClaus-Jürgen Bauer
Claus-Jürgen Bauer
CPCarmen Pizarro
Carmen Pizarro
SPSimon Michael Petzinna
Simon Michael Petzinna
Objectives: This cross-sectional study aimed to determine the prevalence, manifestation, and risk factors of pulmonary involvement in newly diagnosed, untreated rheumatoid arthritis (RA) and psoriatic arthritis (PsA) patients, and to evaluate the efficacy of various diagnostic tools in screening for pulmonary involvement. Methods: Untreated, newly diagnosed patients with RA and PsA underwent an extensive multimodal diagnostic approach including clinical and laboratory assessment, pulmonary function tests, and chest radiography. Results: We recruited 50 arthritis patients (26 RA, 24 PsA) and 26 control subjects. Respiratory symptoms were found in 36.0 % of arthritis patients and 11.5 % of controls (p = 0.031). Pathologically reduced breathing width (< 3.0 cm) was significantly more common in arthritis patients (64.0 %) than in controls (23.1 %) (p < 0.001). Pulmonary function test results did not differ significantly between groups. Chest radiography revealed pulmonary involvement in 37.0 % of arthritis patients, higher in RA (50.0 %) than in PsA (22.7 %). Notably, only 35.3 % of arthritis patients with radiographic pulmonary involvement were symptomatic, with 64.7 % being asymptomatic. Radiographic pulmonary involvement was associated with advanced age (p = 0.002) and increased rheumatoid factor levels (p = 0.024). Conclusion: Our research underscores the significant prevalence of largely asymptomatic pulmonary involvement in newly diagnosed RA and PsA patients. These findings highlight the importance of an early, multidisciplinary screening approach, particularly for high-risk individuals. Further large-scale studies are needed to develop comprehensive screening protocols to improve early detection and treatment of pulmonary involvement in arthritis.

3 February 2025 in Rheumatology
Verified
Journal Article
Closed access
RNRicarda Neubauer
Ricarda Neubauer
Florian Recker, MMEFlorian Recker, MME
Florian Recker, MME
CBClaus-Juergen Bauer
Claus-Juergen Bauer
SPSimon Michael Petzinna
Simon Michael Petzinna
PKPantelis Karakostas
Pantelis Karakostas
Valentin Sebastian SchäferValentin Sebastian Schäfer
Valentin Sebastian Schäfer
Objectives: Despite growing interest in musculoskeletal ultrasound (MSUS), training opportunities are often limited due to staff shortages and disbalances of expertise between rural and urban areas. Teledidactic approaches have the potential to expand access to training opportunities. This study aims to compare the effectiveness of teledidactic peer-tutored MSUS training to a conventional approach. Methods: A teledidactic course was held by a student tutor following a validated MSUS curriculum. An on-campus MSUS training taught by physician lecturers served as a control. Students were randomly assigned to one of both study groups. Objective structured clinical examinations (OSCE) were conducted before and after the training to objectively measure the learning outcome of the participants. Handheld ultrasound devices (ButterflyIQ®) and iPads (Apple Inc., eighth generation) were provided to the students for the MSUS course. Results: Thirty medical students participated in the study. Prior to the course, baseline OSCE scores were recorded as 13.03/63 (SD ± 4.20) for the on-campus cohort and 13.00/63 (SD ± 6.04) for the teledidactic group. In the post-training OSCE evaluation, the on-campus cohort attained an average score of 56.80/63 (SD ± 4.22), while the TELMUS group averagely achieved 58.53/63 points (SD ± 3.52). While all students’ skills increased over time, there was no significant difference between the two cohorts either before or after the course. Conclusion: Peer-tutored, teledidactic MSUS training showed to be non-inferior to the conventional approach and is a promising approach to reduce local and global disparities in educational opportunities regarding MSUS.

21 May 2021 in Diagnostics
Verified
Journal Article
Open access
PDF file
DKDmitrij Kravchenko
Dmitrij Kravchenko
CBCharlotte Behning
Charlotte Behning
Raoul BergnerRaoul Bergner
Raoul Bergner
Valentin Sebastian SchäferValentin Sebastian Schäfer
Valentin Sebastian Schäfer
Clinical differentiation between gout, osteoarthritis (OA), and calcium pyrophosphate deposition disease (CPPD) remains a hurdle in daily practice without imaging or arthrocentesis. We performed a retrospective analysis of consecutive patients with gout, CPPD, and OA at a tertiary rheumatology center. A total of 277 patients were enrolled, with 164 suffering from gout, 76 from CPPD, and 37 from OA. We used ANOVA and conditional inference tree analysis (Ctrees) to find associations between clinical, laboratory, and imaging data and gout, OA, and CPPD. The sonographic double contour sign was unable to differentiate gout from CPPD. Ctrees were able to exclude OA and CPPD as possible differentials based on elevated uric acid, C-reactive protein (CRP), presence of arterial hypertension, and sex, diagnosing gout with a sensitivity and specificity of 95.1% and 41.6%, respectively. Elevated CRP was observed using simple linear regressions in patients with type II diabetes, higher cumulative joint scores, increased number of affected joints, as well as elevated uric acid, erythrocyte sedimentation rate, and leukocyte count. Ctrees were able to differentiate gout, OA, and CPPD based on just four characteristics. Inflammatory response correlated with type II diabetes, more or larger joint involvement, and elevated uric acid levels.